Plasma p-tau217 immunoassay offers accurate detection of Alzheimer’s disease pathology, supporting early diagnosis and ...
A GROUNDBREAKING phase 2b randomized clinical trial has demonstrated that plozasiran, an investigational APOC3-targeted siRNA ...
NOVEL research proposes a shift from clinical to biological definitions for Parkinson’s disease (PD) and dementia with Lewy ...
A RECENT study exploring the impact of multi-ancestry polygenic risk scores (PRS) on prostate cancer progression suggests ...